Fluctuations in glycaemia in clinical diabetes mellitus type 2 are not associated with carotid intima-media thickening

Diabetes & Vascular Disease Research

Volumn 1, Issue 1, 2004, Pages 51-52

  Karrei, Katharina ^a   Koehler, Carsta ^a   Hanefeld, Markolf ^a   Temelkova Kurktschiev, Theodora ^a   Del Prato, Stefano ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; 1,5-ANHYDROGLUCITOL; DEOXYGLUCOSE;

BLOOD; COMMON CAROTID ARTERY; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INTIMA; LETTER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; TUNICA MEDIA;

BLOOD GLUCOSE; CAROTID ARTERY, COMMON; CROSS-SECTIONAL STUDIES; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; HYPERGLYCEMIA; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 33644673417     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2004.007     Document Type: Article

References (11)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035–2038.
2. Castelli WP, Wilson PW, Levy D, Anderson K. Cardiovascular risk factors in the elderly. Am J Cardiol 1989; 63: 12H–19H.
3. Temelkova-Kurktschiev T, Köhler C, Schaper F et al. Beziehung zwischen verschiedenen Stadien der Glukosetoleranz, etablierten Risikofaktoren für Arteriosklerose und Intima-Media. Dicke (IMD) der A. carotis communis. Diabetes und Stoffwechsel 1998; 7: 227–232.
4. Yamanouchi T, Minoda S, Yabuuchi M et al. Plasma 1, 5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients. Diabetes 1989; 38: 723–729.
5. Yamanouchi T, Moromizato H, Shinohara T et al. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1, 5–anhydroglucitol. Metabolism 1992; 41: 862–867.
6. Fukumura Y, Tajima S, Oshitani S et al. Fully enzymatic method for determining 1, 5-anhydro-D-glucitol in serum. Clin Chem 1994; 40: 2013–2016.
7. Fontbonne A, Charles MA, Thibult N et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study 15-year follow-up. Diabetologia 1991; 34: 356–361.
8. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ (Clin Res Ed) 1983; 287: 867–870.
9. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 1999; 144: 229–235.
10. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131–141.
11. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS). Lancet 1998; 352: 837–853.